Conversion to the COBAS AmpliPrep/COBAS TaqMan CMV Test for management of CMV disease in transplant recipients-Reference-Cited by-同舟云学术

Conversion to the COBAS AmpliPrep/COBAS TaqMan CMV Test for management of CMV disease in transplant recipients

Published:2013-04 Issue:4 Volume:75 Page:440-442
ISSN:0732-8893
Container-title:Diagnostic Microbiology and Infectious Disease
language:en
Short-container-title:Diagnostic Microbiology and Infectious Disease

Author:

Pritt Bobbi S.,Germer Jeffrey J.,Gomez-Urena Eric,Bishop Callie J.,Mandrekar Jayawant N.,Irish Cole L.,Yao Joseph D.C.

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),General Medicine

Reference8 articles.

1. Monitoring human cytomegalovirus infection in transplant recipients;Baldanti;J Clin Virol,2008

2. Fryer JF, Heath AB, Anderson R, Minor PD. Collaborative study to evaluate the proposed 1st WHO International Standard for human cytomegalovirus (HCMV) for nucleic acid amplification (NAT)-based assays. 2010;WHO ECBS Report 2010 WHO/BS/10.2138.

3. Precision across the analytical measuring range of a quantitative real-time PCR assay for cytomegalovirus detection among three clinical laboratories;Grys;J Clin Microbiol,2011

4. Clinical evaluation of a fully automated CMV PCR assay;Kerschner;J Clin Virol,2011

5. International consensus guidelines on the management of cytomegalovirus in solid organ transplantation;Kotton;Transplantation,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Relationship of Ganciclovir Therapeutic Drug Monitoring with Clinical Efficacy and Patient Safety;Antimicrobial Agents and Chemotherapy;2019-03

2. Cytomegalovirus sequence variability, amplicon length, and DNase-sensitive non-encapsidated genomes are obstacles to standardization and commutability of plasma viral load results;Journal of Clinical Virology;2018-07

3. Humanes Cytomegalievirus (HCMV);Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz;2017-12-27

4. Cytomegalovirus viraemia and mortality in renal transplant recipients in the era of antiviral prophylaxis. Lessons from the western Australian experience;BMC Infectious Diseases;2017-07-17

5. Treatment of cytomegalovirus infection and disease pre- and post-quantitative nucleic acid test standardization: does use of a more sensitive assay lead to longer treatment duration?;Clinical Transplantation;2016-01-06